PKM2-Driven Glycolysis and Rotenone Neurotoxicity in Parkinson’s Disease
Beyond the Mitochondria: The New Metabolic Frontier in the Fight Against Parkinson’s Disease For decades, the scientific community has viewed Parkinson’s disease (PD) through a relatively narrow lens: mitochondrial dysfunction. The prevailing wisdom suggested that the breakdown of the cell’s “powerhouse” was the primary driver of neuronal death. However, a paradigm shift is underway. New … Read more